Atreca Operating Income

Atreca (BCEL) currently reports a operating income of $-60M as of September 2023. That compares with $-190M in the prior-year period — up 67.5% year over year. Use the charts on this page to explore Atreca's operating income history and peer comparisons.

Atreca's operating income increased from $-190M to $-60M — a 67.5% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Atreca reported $-60M in operating income as of September 2023. That compares with $-190M in the prior-year period — up 67.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-60M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atreca, and consider following BCEL for alerts when major investors trade the stock.

Atreca is classified in the Healthcare sector. On operating income, it currently shows $-60M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BCEL with unrelated industries.